| Dr Michelle Edith Cevallos, OD | |
|
5353 Sw College Rd, Ocala, FL 34474-5717 | |
| (352) 512-0560 | |
| Not Available |
| Full Name | Dr Michelle Edith Cevallos |
|---|---|
| Gender | Female |
| Speciality | Optometry |
| Experience | 16 Years |
| Location | 5353 Sw College Rd, Ocala, Florida |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104070788 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | TUV007321 (New York) | Secondary |
| 152W00000X | Optometrist | 27OA00618600 (New Jersey) | Secondary |
| 152W00000X | Optometrist | OPC4874 (Florida) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Aeg Florida Professional Pllc | 3870960032 | 24 |
News Archive
Researchers at the Novo Nordisk Foundation Center for Biosustainability in Denmark have developed a method of producing P450 enzymes - used by plants to defend against predators and microbes - in bacterial cell factories. The process could facilitate the production of large quantities of the enzymes, which are also involved in the biosynthesis of active ingredients of cancer drugs.
An Australian psychiatrist has accused the medical profession of over-diagnosing depression, and says thousands of people are wrongly being prescribed drugs to treat it.
The Michael J. Fox Foundation (MJFF) today announced that it has awarded $1.5 million to AFFiRiS AG, a Vienna, Austria-based biotech company, for a clinical study of AFFITOPE PD01, a first-of-its-kind Parkinson's disease (PD) vaccine.
Pheochromocytomas and paragangliomas are rare neuroendocrine tumors with a strong hereditary component. Half the genes whose alterations confer hereditary susceptibility to develop this condition code for enzymes involved in the Krebs cycle, a metabolic route involved in cellular respiration.
Lexicon Pharmaceuticals, Inc.'s telotristat etiprate, the first oral therapy in development for the treatment of carcinoid syndrome (CS), was associated with patient-reported improvements in social and physical function and emotional well-being according to new exit interview data from the Phase 3 TELESTAR study presented at the 2015 Neuroendocrine Tumor Society Annual Symposium in Austin, Texas.
› Verified 3 days ago
| Provider Name | Eye Doctors Optical Outlets Pa |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1114012689 PECOS PAC ID: 0042123846 Enrollment ID: O20031107000478 |
News Archive
Researchers at the Novo Nordisk Foundation Center for Biosustainability in Denmark have developed a method of producing P450 enzymes - used by plants to defend against predators and microbes - in bacterial cell factories. The process could facilitate the production of large quantities of the enzymes, which are also involved in the biosynthesis of active ingredients of cancer drugs.
An Australian psychiatrist has accused the medical profession of over-diagnosing depression, and says thousands of people are wrongly being prescribed drugs to treat it.
The Michael J. Fox Foundation (MJFF) today announced that it has awarded $1.5 million to AFFiRiS AG, a Vienna, Austria-based biotech company, for a clinical study of AFFITOPE PD01, a first-of-its-kind Parkinson's disease (PD) vaccine.
Pheochromocytomas and paragangliomas are rare neuroendocrine tumors with a strong hereditary component. Half the genes whose alterations confer hereditary susceptibility to develop this condition code for enzymes involved in the Krebs cycle, a metabolic route involved in cellular respiration.
Lexicon Pharmaceuticals, Inc.'s telotristat etiprate, the first oral therapy in development for the treatment of carcinoid syndrome (CS), was associated with patient-reported improvements in social and physical function and emotional well-being according to new exit interview data from the Phase 3 TELESTAR study presented at the 2015 Neuroendocrine Tumor Society Annual Symposium in Austin, Texas.
› Verified 3 days ago
| Provider Name | Shaw Eye Care Associates |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1316177017 PECOS PAC ID: 2062550874 Enrollment ID: O20091117000077 |
News Archive
Researchers at the Novo Nordisk Foundation Center for Biosustainability in Denmark have developed a method of producing P450 enzymes - used by plants to defend against predators and microbes - in bacterial cell factories. The process could facilitate the production of large quantities of the enzymes, which are also involved in the biosynthesis of active ingredients of cancer drugs.
An Australian psychiatrist has accused the medical profession of over-diagnosing depression, and says thousands of people are wrongly being prescribed drugs to treat it.
The Michael J. Fox Foundation (MJFF) today announced that it has awarded $1.5 million to AFFiRiS AG, a Vienna, Austria-based biotech company, for a clinical study of AFFITOPE PD01, a first-of-its-kind Parkinson's disease (PD) vaccine.
Pheochromocytomas and paragangliomas are rare neuroendocrine tumors with a strong hereditary component. Half the genes whose alterations confer hereditary susceptibility to develop this condition code for enzymes involved in the Krebs cycle, a metabolic route involved in cellular respiration.
Lexicon Pharmaceuticals, Inc.'s telotristat etiprate, the first oral therapy in development for the treatment of carcinoid syndrome (CS), was associated with patient-reported improvements in social and physical function and emotional well-being according to new exit interview data from the Phase 3 TELESTAR study presented at the 2015 Neuroendocrine Tumor Society Annual Symposium in Austin, Texas.
› Verified 3 days ago
| Provider Name | Aeg Florida Professional Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1164156246 PECOS PAC ID: 3870960032 Enrollment ID: O20221101003017 |
News Archive
Researchers at the Novo Nordisk Foundation Center for Biosustainability in Denmark have developed a method of producing P450 enzymes - used by plants to defend against predators and microbes - in bacterial cell factories. The process could facilitate the production of large quantities of the enzymes, which are also involved in the biosynthesis of active ingredients of cancer drugs.
An Australian psychiatrist has accused the medical profession of over-diagnosing depression, and says thousands of people are wrongly being prescribed drugs to treat it.
The Michael J. Fox Foundation (MJFF) today announced that it has awarded $1.5 million to AFFiRiS AG, a Vienna, Austria-based biotech company, for a clinical study of AFFITOPE PD01, a first-of-its-kind Parkinson's disease (PD) vaccine.
Pheochromocytomas and paragangliomas are rare neuroendocrine tumors with a strong hereditary component. Half the genes whose alterations confer hereditary susceptibility to develop this condition code for enzymes involved in the Krebs cycle, a metabolic route involved in cellular respiration.
Lexicon Pharmaceuticals, Inc.'s telotristat etiprate, the first oral therapy in development for the treatment of carcinoid syndrome (CS), was associated with patient-reported improvements in social and physical function and emotional well-being according to new exit interview data from the Phase 3 TELESTAR study presented at the 2015 Neuroendocrine Tumor Society Annual Symposium in Austin, Texas.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michelle Edith Cevallos, OD 5353 Sw College Rd, Ocala, FL 34474-5717 Ph: () - | Dr Michelle Edith Cevallos, OD 5353 Sw College Rd, Ocala, FL 34474-5717 Ph: (352) 512-0560 |
News Archive
Researchers at the Novo Nordisk Foundation Center for Biosustainability in Denmark have developed a method of producing P450 enzymes - used by plants to defend against predators and microbes - in bacterial cell factories. The process could facilitate the production of large quantities of the enzymes, which are also involved in the biosynthesis of active ingredients of cancer drugs.
An Australian psychiatrist has accused the medical profession of over-diagnosing depression, and says thousands of people are wrongly being prescribed drugs to treat it.
The Michael J. Fox Foundation (MJFF) today announced that it has awarded $1.5 million to AFFiRiS AG, a Vienna, Austria-based biotech company, for a clinical study of AFFITOPE PD01, a first-of-its-kind Parkinson's disease (PD) vaccine.
Pheochromocytomas and paragangliomas are rare neuroendocrine tumors with a strong hereditary component. Half the genes whose alterations confer hereditary susceptibility to develop this condition code for enzymes involved in the Krebs cycle, a metabolic route involved in cellular respiration.
Lexicon Pharmaceuticals, Inc.'s telotristat etiprate, the first oral therapy in development for the treatment of carcinoid syndrome (CS), was associated with patient-reported improvements in social and physical function and emotional well-being according to new exit interview data from the Phase 3 TELESTAR study presented at the 2015 Neuroendocrine Tumor Society Annual Symposium in Austin, Texas.
› Verified 3 days ago
Dr. Kathryn Mar Jip Pomakis, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 4414 Sw College Rd Ste 1462, Ocala, FL 34474 Phone: 352-622-5183 Fax: 352-629-5026 | |
Eyepromote, Inc. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2775 Nw 49th Ave, Suite 205-146, Ocala, FL 34482 Phone: 239-851-2577 | |
Dr Aileen Lamela Od Pa Optometrist Medicare: Medicare Enrolled Practice Location: 4980 E Silver Springs Blvd, Ocala, FL 34470 Phone: 352-861-4544 | |
Dr. April Joy Fisher, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 3307 Sw 26th Ave, Ocala, FL 34471 Phone: 352-861-3969 | |
Myeyedr. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 3101 Sw College Rd, Ocala, FL 34474 Phone: 352-237-3768 | |
Dr. James C. Williams, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 3230 Sw 33rd Rd, Ocala, FL 34474 Phone: 352-237-0090 Fax: 352-237-0052 |